Determination of sarcosine in urine as a predictor of prostate cancer using Enzyme linked immunosorbent method
The Journal of Medical Research · 2023
DOI: 10.31254/jmr.2023.9102 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Medical Research, 2023. Verfasst von Mukaa M Januaris und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Prostate cancer is a type of malignancy that is defined by abnormal development of cells in the prostate tissue. Prostate cancer needs early intervention since its incidence and prevalence is high across the world leading to high morbidity and mortality. Prostatic specific antigen test which is the commonly used screening test in Kenya and across the world is nonspecific, expensive and inaccessible to many people in rural setting who are in need. The definitive histological test is invasive and requires specialized facilities and personnel. This study sought to investigate sarcosine in urine as a predictor of prostate cancer to supplement prostatic specific antigen test in the diagnosis of prostate carcinoma. Cross sectional study design was employed in this study for all suspected prostate cancer identified according to clinical assessment during the study period. Midstream urine samples of about 30mls was collected in plastic tubes, centrifuged and supernatant collected and analyzed using ELISA method for sarcosine. Raw data obtained was tabulated in excel and transferred to statistical package for social science. Differences in means and standard deviation from various age groups was analyzed using one-way Anova and Independent t test. The Bonferroni was used as post Hoc to test the means that were significant from others. Significance level was set at 95%. The concentration of sarcosine (4.30±0.11nmol/ml) in prostate cancer participants was significantly higher than the concentration (0.47±0.06nmol/ml) of control participants using ELISA (p
Zitieren
APA
Januaris, M. M., Njoroge, W. G., Radol, A. O., & Waweru, J. G. (2023). Determination of sarcosine in urine as a predictor of prostate cancer using Enzyme linked immunosorbent method. The Journal of Medical Research. https://doi.org/10.31254/jmr.2023.9102
Vancouver
Januaris MM, Njoroge WG, Radol AO, Waweru JG. Determination of sarcosine in urine as a predictor of prostate cancer using Enzyme linked immunosorbent method. The Journal of Medical Research. 2023. doi:10.31254/jmr.2023.9102
BibTeX
@article{Januaris2023,
author = {Januaris, Mukaa M and Njoroge, Wachuka Gathigia and Radol, Antony Omondi and Waweru, Jeremiah Gathirwa},
title = {Determination of sarcosine in urine as a predictor of prostate cancer using Enzyme linked immunosorbent method},
journal = {The Journal of Medical Research},
year = {2023},
doi = {10.31254/jmr.2023.9102}
}
EUVIMED